Dose-Related Levodopa-Induced Haemolytic Anaemia

  1. FOLKE D. LINDSTRÖM, M.D.;
  2. GUDRUN LIEDÉN, M.D.; and
  3. MARGARETA S. ENGSTRÖM, M.D.
  1. Linköping
    , Sweden

    Abstract

    A 71-year-old white man developed direct antiglobulin positive haemolytic anaemia after 16 months of levodopa therapy for Parkinson's disease. Immunoglobulin G autoantibodies directed against Rh antigens were found in the patient's serum and on his erythrocytes. Reduction of levodopa dosage to one sixth with the aid of a peripheral decarboxylase inhibitor (benserazide) largely eliminated autoimmune haemolysis while maintaining adequate control of neurologic symptoms.

    Article and Author Information

    • ▸From the Department of Internal Medicine and the Blood Centre, University Hospital; Linköping, Sweden.

    • ▸Requests for reprints should be addressed to Folke D. Lindström, M.D.; Department of Medicine, University of Linköping School of Medicine; 581 85 Linköping, Sweden.

      • Received April 7, 1976.
      • Accepted December 17, 1976.
    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement